AMPH STOCK ALERT: Levi & Korsinsky Notifies Amphastar Pharmaceuticals, Inc. Investors of an Ongoing Investigation
Portfolio Pulse from
Levi & Korsinsky has initiated an investigation into Amphastar Pharmaceuticals, Inc. for potential violations of federal securities laws. This follows an FDA complete response letter regarding Amphastar's generic teriparatide ANDA, AMP-015.
February 26, 2025 | 12:45 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Amphastar Pharmaceuticals is under investigation by Levi & Korsinsky for potential securities law violations. This comes after the FDA issued a complete response letter for its generic teriparatide ANDA, AMP-015.
The investigation by Levi & Korsinsky and the FDA's complete response letter are likely to negatively impact Amphastar's stock in the short term. The legal scrutiny and regulatory setback could lead to investor concerns and potential sell-offs.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100